Ringo Starr Finds His Finest Late-Career Voice on "Long Long Road"
At 85, Ringo Starr has made one of the most quietly assured records of his fifty-plus-year solo career. Long Long Road, his twenty-second studio album, continues the country-inflected direction he
Daines Retirement Opens a Senate Race and Closes a Door on Cannabis Banking
Steve Daines won't seek a third term in the U.S. Senate, and for Democrats eyeing the chamber's math in 2026, Montana just got interesting. But the announcement carries a quieter consequence for an
Cannabis Rescheduling Leaves Banking Barriers Largely Intact for Most Operators
The federal reclassification of cannabis from Schedule I to Schedule III was supposed to mark a turning point. For tax purposes and research access, it does. For the majority of cannabis businesses
Oklahoma Judge Restores License to Major Cannabis Cultivator After State Crackdown
Cedric Gardens, one of Oklahoma's largest medical marijuana cultivators, won back its right to operate on Monday after a state judge rejected the claims that led regulators to suspend its license in
Federal Marijuana Rescheduling Order Gives Hawai'i Lawmakers New Hope for Cannabis Reform
After years of watching his recreational cannabis bills die quiet deaths in the Hawai'i State Legislature, Big Island Representative David Tarnas has found an unlikely source of optimism: the Trump
Fine Fettle Dispensary Opens as Athens' First Medical Cannabis Outlet
Judson Hill knows the wreckage of a tractor-trailer collision firsthand—t-boned at age 20, he rejected prescription pills and turned to cannabis for relief. Fourteen years on, he's Georgia Market
MedGenome Secures Majority Stake in Green Cross Genetics Lab to Boost Gujarat Diagnostics
MedGenome, a global leader in genomics-driven diagnostics and research, has acquired a majority investment in Green Cross Genetics Lab, a Gujarat-based pathology chain with over 30 years of
Green Cross Builds U.S. Growth Base with Alyglo Blood Product Success
South Korean biotech firm Green Cross has laid a solid foundation for mid-to-long-term expansion in the U.S. market through its intravenous immunoglobulin product Alyglo. Analysts at Heungkuk
Green Cross Health Explores Sale of Medical Division Amid Strategic Talks
Green Cross Health has confirmed discussions with third parties over a potential transaction for its Medical division, which operates The Doctors brand across 65 medical centres. This development